PAMP
ABMD

Polar Asset Management Partners’s Abiomed Inc ABMD Stock Holding History

Polar Asset Management Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-118,300
Closed -$29.3M – 1514
2022
Q2 		$29.3M Buy
+118,300
New +$31.9M 0.34% 45

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Polar Asset Management Partners's ABMD Position: Q3 2022 in Review

Polar Asset Management Partners sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 118,300 shares — an estimated $29.3M sold.

Polar Asset Management Partners first reported a position in ABMD in Q2 2022 and held it in 1 quarter. The position peaked at $29.3M in Q2 2022. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Polar Asset Management Partners reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Polar Asset Management Partners sold 118,300 Abiomed Inc shares in Q3 2022, an estimated $29.3M.
  • Polar Asset Management Partners first reported a position in Abiomed Inc in Q2 2022 and held it in 1 quarter.
  • Polar Asset Management Partners's Abiomed Inc position peaked at $29.3M in Q2 2022.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Polar Asset Management Partners's 13F filing for Q3 2022, filed 14 Nov 2022.